Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 1 Apr 2015

Randhawa P, Pastrana D V, Zeng G, Huang Y, Shapiro R, Sood P, Puttarajappa C, Berger M, Hariharan S, Buck C B

Abstract excerpt

Neutralizing antibodies (NAbs) form the basis of immunotherapeutic strategies against many important human viral infections. Accordingly, we studied the prevalence, titer, genotype-specificity, and mechanism of action of anti-polyomavirus BK (BKV) NAbs in commercially available human immune globulin (IG) preparations designed for intravenous (IV) use. Pseudovirions (PsV) of genotypes Ia, Ib2, Ic, II, III, and IV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to BK Virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line

Share to Genes, Viral

Share to Genotype

Share to Immunoglobulins

Share to Parvovirus B19 Infection Studies

Share to Polyomavirus and related diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 25736704
DOI: 10.1111/ajt.13083
PMCID: PMC8320700

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.PMID 25736704Read ↗

Broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypes.Semantic proximity Read ↗

Broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypesSemantic proximity Read ↗

BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.Semantic proximity Read ↗

Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant RecipientsSemantic proximity Read ↗

Natural and patient-derived mutations in BK polyomavirus VP1 reveal structural determinants of BC-loop dependent antibody escapeSemantic proximity Read ↗

BK polyomavirus genotypes in renal transplant recipients in the United States: A meta-analysis.Semantic proximity Read ↗

Immune responses to BK polyomavirus in healthy donors and renal transplant recipientsSemantic proximity Read ↗

Structural implications of BK polyomavirus sequence variations in the major viral capsid protein Vp1 and large T-antigen: a computational study.Semantic proximity Read ↗

Molecular epidemiology and humoral immunity of BK polyomavirus in the general population of Southern China.Semantic proximity Read ↗

Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients.Semantic proximity Read ↗

Validation of the QIAsymphony RGQ system for DNA quantitation of different BK virus genotypes in whole blood samples.Semantic proximity Read ↗

Genotyping of polyomavirus BK by Real Time PCR for VP1 gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.